Spectrum Direct Insurance Services, Inc. – Trademark Portfolio
Entity Type: 03
Spectrum Direct Insurance Services, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ELIFE. The owner is based in Mission Viejo, CA.
Suite 100
Mission Viejo, CA 92691
Showing of trademarks Trademarks
Trademark Classifications
Spectrum Direct Insurance Services, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Spectrum Direct Insurance Services, Inc. have?
Spectrum Direct Insurance Services, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 cancelled.
What trademark classes does Spectrum Direct Insurance Services, Inc. file in?
Spectrum Direct Insurance Services, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Spectrum Direct Insurance Services, Inc.'s most well-known trademarks?
Spectrum Direct Insurance Services, Inc.'s registered trademark portfolio includes well-known marks such as ELIFE. These are among 1 currently registered trademark in the portfolio.
What is Spectrum Direct Insurance Services, Inc.'s trademark registration success rate?
Spectrum Direct Insurance Services, Inc. has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.